Percutaneous Treatment of Left Side Cardiac Valves

Size: px
Start display at page:

Download "Percutaneous Treatment of Left Side Cardiac Valves"

Transcription

1 Percutaneous Treatment of Left Side Cardiac Valves Ferrarotto Hospital ETNA Foundation

2 Corrado Tamburino Gian Paolo Ussia Percutaneous Treatment of Left Side Cardiac Valves A Practical Guide for the Interventional Cardiologist In collaboration with Davide Capodanno Massimiliano Mulè

3 Corrado Tamburino Full Professor of Cardiology, Director of, Chief Cardiovascular Department, Director Cardiology Division and Interventional Cardiology, Ferrarotto Hospital,, ETNA Foundation, Gian Paolo Ussia Co-Director Interventional Cardiology, Director Structural Heart Disease Program Cardiology Division, Ferrarotto Hospital, In collaboration with Davide Capodanno Research Fellow, Chair of Cardiology Division,, ETNA Foundation, Massimiliano Mulè Research Fellow, Chair of Cardiology Division,, ETNA Foundation, The authors thank the Associazione Cuore e Ricerca of Catania for the technical and scientific support in the realization of this volume ISBN e-isbn DOI / Springer Dordrecht Heidelberg London Milan New York Library of Congress Control Number: Springer-Verlag Italia 2010 This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data banks. Duplication of this publication or parts thereof is permitted only under the provisions of the Italian Copyright Law in its current version, and permission for use must always be obtained from Springer. Violations are liable to prosecution under the Italian Copyright Law. The use of general descriptive names, registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature Drawings by: Giombattista Barrano Anatomopathologic pictures by: Giovanni Bartoloni Typesetting: Compostudio, Cernusco s/n (Milan), Italy Printing and binding: Arti Grafiche Nidasio, Assago (Milan), Italy Printed in Italy Springer-Verlag Italia S.r.l, Via Decembrio 28, I Milan, Italy Springer is part of Springer Science+Business Media (

4 This volume is dedicated to the real engine of research, motivating force of passion and mental vivacity: my students, young doctors and fellows to whom I wish to say a sincere thank you Corrado Tamburino

5 Preface Transcatheter therapy of cardiac valve diseases is a rediscovery by interventional cardiologists. Treating cardiac valve diseases with alternative techniques to cardiac surgery using prosthetic devices has rekindled interest in the field of hemo-dynamics, which has been neglected in recent years. Within this framework, two sectors can be distinguished: valvuloplasty techniques using a balloon alone to treat mitral, aortic, and pulmonary stenoses, and those using prosthetic heart valves or repair devices. Valvuloplasty techniques should be considered as palliative, as the duration of their effectiveness varies from just a few weeks, as in the case of aortic valvuloplasty for degenerative stenoses, to years, as in the case of mitral and pulmonary valvuloplasty. By contrast, transcatheter implantation of biological prosthetic valves, or repair techniques using dedicated devices aim to provide a definitive therapeutic solution or at least a solution offering results that are equal to or just as good as those of cardiac surgery. The advent of devices for the percutaneous treatment of left chamber valve diseases is one of the greatest breakthroughs in interventional cardiology. The goal of this handbook is to give interventional cardiologists the means to understand the context of the percutaneous treatment of valve diseases and the state of the art of the techniques and procedures currently available. Catania, April 2010 Corrado Tamburino Gian Paolo Ussia VII

6 Contents 1 Anatomy 1.1 Mitral Valve Anatomy Mitral Leaflets and the Dynamics of Their Movement The Annulus The Chordae Tendineae and Papillary Muscles Aortic Valve Anatomy The Annulus The Leaflets The Commissures The Interleaflet Triangles The Sinuses of Valsalva The Sinotubular Junction References Mitral Valve Disease 2.1 Mitral Stenosis The Pathophysiology of Mitral Stenosis Diagnosis Non-invasive Diagnosis Invasive Diagnosis Timing of Interventions Patient Selection Percutaneous Therapy Procedure and Technical Aspects Mitral Valvuloplasty Outcomes Complications Mitral Regurgitation The Pathophysiology of Mitral Regurgitation Physiopathology Diagnosis Non-invasive Diagnosis IX

7 X Contents Invasive Diagnosis Timing of Interventions Patient Selection Anatomical and Functional Assessment of the Mitral Valve Assessment of Regurgitation Etiopathogenesis Selection of Patients for Implantation Percutaneous Therapy Leaflets Repair Transcatheter Coronary Sinus Techniques Annuloplasty Techniques Chamber and Annular Remodeling A Glimpse into the Future References Aortic Valve Disease 3.1 Aortic Stenosis The Pathophysiology of Aortic Stenosis Diagnosis Non-invasive Diagnosis Invasive Diagnosis Timing of Interventions Symptomatic Patients Asymptomatic Patients Patient Selection Valve Annulus Sinuses of Valsalva (Width and Height) Sinotubular Junction (STJ) Left Ventricular Outflow Tract Ascending Aorta Iliac-femoral Axis and Subclavian Artery Percutaneous Therapy Edwards-SAPIEN Valve CoreValve ReValving System Other Devices Procedural Complications Aortic Regurgitation The Pathophysiology of Aortic Regurgitation Diagnosis Non-invasive Diagnosis Invasive Diagnosis Timing of Interventions Patient Selection

8 Contents XI Percutaneous Therapy References Tips and Tricks and Management of Complications in Valvular Interventional Cardiology 4.1 Patient Selection and Work-up Anatomical Typing Valve and Heart Anatomy Vascular Anatomy Femoral Arteries Iliac Arteries Abdominal Aorta Thoracic Aorta Procedure Vascular Access Choosing the Introducer Passing the Aortic Valve Valvuloplasty CoreValve Revalving System Delivery and Implantation Check on Implantation Closing the Arterial Breach with the Prostar Device Miscellaneous Difficult Navigation of the Delivery Catheter in the Aortic Arch Recovery of Catheter Fragments Balloon Valvuloplasty Trapping Cardiac Perforation Introducer Replacement The MitraClip Device and Technique Procedure Reference Transcatheter Valve Treatment: Peri-procedural Management 5.1 Pre-procedural Care Post-procedural Management ICU Care Laboratory Tests Renal Function and Fluid Balance Vascular Access Rhythm Control

9 XII Contents Transthoracic Echocardiogram Medical Treatment and Physical Rehabilitation Before Hospital Discharge Medium-term Management (Out of Hospital) References Surgical Treatment of Mitral Regurgitation and Aortic Stenosis 6.1 Treatment of Degenerative Mitral Regurgitation Epidemiology and Natural History Diagnosis and Quantification of Degenerative Mitral Regurgitation Surgical Considerations Types of Procedure Surgical Indications Principles of Mitral Repair Surgery Results Treatment of Functional Mitral Regurgitation Treatment of Aortic Stenosis Surgical Indications Specific Issues Mechanical or Tissue Valves Prosthesis Patient Mismatch The Role of Transfemoral or Transapical Aortic Valve Replacement References

10 List of Authors and Contributors Corrado Tamburino Full Professor of Cardiology Director of Postgraduate School of Cardiology Chief of Cardiovascular Department Director of Cardiology Division and Interventional Cardiology Ferrarotto Hospital ETNA Foundation Gian Paolo Ussia Co-Director of Interventional Cardiology Director Structural Heart Disease Program Cardiology Division Ferrarotto Hospital Davide Capodanno Research Fellow Chair of Cardiology Division ETNA Foundation Massimiliano Mulè Research Fellow Chair of Cardiology Division ETNA Foundation Ottavio Alfieri Full Professor of Cardiac Surgery Director Cardiac Surgery San Raffaele University Hospital Milan, Italy Antonio Maria Calafiore Full Professor of Cardiac Surgery Department of Adult Cardiac Surgery Prince Sultan Cardiac Center Riyadh, Saudi Arabia XIII

11 XIV List of Authors and Contributors George Dangas Cardiovascular Research Foundation New York, USA Cardiology Department Onassis Cardiac Surgery Centre Athens, Greece Ted Feldman Division of Cardiology Evanston Hospital University of Illinois, US Patrizia Aruta Marco Barbanti Gionbattista Barrano Giovanni Bartoloni Professor of Anatomic Pathology Michele De Bonis Cardiac Surgery San Raffaele Hospital Milan, Italy Valeria Cammalleri Wanda Deste Echocardiography Laboratory Division of Cardiology Ferrarotto Hospital Lorena Iacò Department of Adult Cardiac Surgery Prince Sultan Cardiac Center Riyadh, Saudi Arabia Sebastiano Immè Sarah Mangiafico Echocardiography Laboratory Division of Cardiology Ferrarotto Hospital Anna Marchese Anna Maria Pistritto Salvatore Scandura Director of Echocardiography Laboratory Division of Cardiology Ferrarotto Hospital Marilena Scarabelli

12 List of Authors and Contributors XV Konstantinos Spargias Cardiology Department Onassis Cardiac Surgery Centre Athens, Greece Maurizio Taramasso Cardiac Surgery San Raffaele Hospital Milan, Italy Adel Tash Department of Adult Cardiac Surgery Prince Sultan Cardiac Center Riyadh, Saudi Arabia Laura Basile Executive PA ETNA Foundation

13 Abbreviations ACC ACE ACT AHA AIV AL-1/AL-2 AMADEUS AR AS ASA ASD ASS AVA AVB AVR bpm CABG CC CD CDS CI CIMR CIN CK CL CRS CT CVRS CW American College of Cardiology angiotensin-converting enzyme activated clotting time American Heart Association anterior atrioventricular vein Amplatz Left-1/2 (catheter) Mitral Annuloplasty Device European Study aortic regurgitation aortic stenosis acetylsalicylic acid atrial septal defect Amplatz Super Stiff (guidewire) aortic valve area atrioventricular block aortic valve replacement beats/min coronary artery bypass grafting intercommisural distance coaptation distance clip delivery system confidence interval chronic ischemic mitral regurgitation contrast-induced nephropathy creatine kinase coaptation length CoreValve ReValving System computed tomography cardiovascular valve repair system continuous wave (Doppler) XVII

14 XVIII Abbreviations CWP capillary wedge pressure 2D two-dimensional 3D three-dimensional DCS delivery catheter system DT deceleration E-time ECG electrocardiogram ECMO extracorporeal membrane oxygenation EF ejection fraction EOA effective orifice area ERO effective regurgitant orifice EROA effective regurgitant orifice area ES Edwards-SAPIEN (heart valve) ESC European Society of Cardiology EuroSCORE European System for Cardiac Operative Risk Evaluation EVEREST Endovascular Edge-to-edge Repair Study Trial EVOLUTION EValuation Of the Edwards Lifesciences percutaneous mitral annuloplasty system for the treatment of mitral regurgitation FH Ferrarotto Hospital (Catania) FIM First In Man (study) FMR functional mitral regurgitation FSV forward stroke volume HIT heparin-induced thrombocytopenia IAS inter-atrial septum ICU intensive care unit IMR ischemic mitral regurgitation INR international normalized ratio JR Judkins catheter IV intravenous LA left atrium LAA left atrial appendage LAP left atrial pressure LBBB left bundle branch block LDH lactic dehydrogenase LIMA left internal mammary artery LMCA left main coronary artery LMWH low molecular weight heparin LV left ventricle LVDP left ventricular diastolic pressure LVEDP left ventricular end-diastolic pressure LVEF left ventricle ejection fraction LVESD left ventricular end-systolic diameter LVESV left ventricular end-systolic volume LVESVI left ventricular end-systolic volume index

15 Abbreviations XIX LVOT MACCE MAE MI ML MP MR MRI MSCT MVA NHLBI NYHA OR OS PAP PCWP PHT PISA PMC PMV PPM PTMA PTOLEMY PVF PW RBBB RF RR RV S 1 S 2 S 3 SAM SGC SL SLE spap SRH STJ STS STS-PROM TA TAVI left ventricular outflow tract major adverse cardiac and cerebrovascular event major adverse event myocardial infarction mid-lateral multipurpose catheter mitral regurgitation magnetic resonance imaging multislice computed tomography mitral valve area National Heart, Lung, and Blood Institute New York Heart Association odds ratio opening snap pulmonary artery pressure pulmonary capillary wedge pressure pressure half-time proximal isovelocity surface area percutaneous mitral commisurotomy percutaneous mitral valvulotomy prosthesis patient mismatch percutaneous transvenous mitral annuloplasty Percutaneous Mitral Annuloplasty (trial) pulmonary venous flow pulsed wave (Doppler) right bundle branch block regurgitant fraction risk ratio regurgitant volume first heart sound second heart sound third heart sound systolic anterior motion steerable guide catheter septal lateral distance systemic lupus erythematosus systolic pulmonary artery pressure San Raffaele Hospital (Milan) sinotubular junction Society of Thoracic Surgeons STS Predicted Risk of Mortality tenting area transcatheter aortic valve implantation

16 XX Abbreviations TEE TIA TSV TTE UFH UGCR VC VKA transesophageal echocardiogram/echocardiography transient ischemic attack total stroke volume transthoracic echocardiogram/echocardiography unfractionated heparin ultrasound-guided compression repair vena contracta vitamin K antagonist

Percutaneous Treatment of Left Side Cardiac Valves. Societa Italiana

Percutaneous Treatment of Left Side Cardiac Valves. Societa Italiana Percutaneous Treatment of Left Side Cardiac Valves Societa Italiana --- -- Ferrarotto Hospital ETNA Foundution University of Catania di Cardiologia Invasiva Corrado Tamburino Gian Paolo Ussia ercutaneous

More information

Percutaneous Treatment of Left Side Cardiac Valves. Societa Italiana

Percutaneous Treatment of Left Side Cardiac Valves. Societa Italiana Percutaneous Treatment of Left Side Cardiac Valves Societa Italiana --- -- Ferrarotto Hospital ETNA Foundution University of Catania di Cardiologia Invasiva Corrado Tamburino Gian Paolo Ussia ercutaneous

More information

Left Main Coronary Artery Disease

Left Main Coronary Artery Disease Left Main Coronary Artery Disease Ferrarotto Hospital ETNA Foundation Corrado Tamburino Left Main Coronary Artery Disease A Practical Guide for the Interventional Cardiologist In collaboration with Maria

More information

Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation

Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation ESC Congress 2010 28 Aug 2010-01 Sep 2010 Stockholm - Sweden Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation Gian Paolo Ussia, MD Director of Interventional

More information

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Ablation, of mitral leaflets, 80 Accucinch Annuloplasty system, for mitral regurgitation, 79, 94 95 Accutrak delivery system, for CoreValve

More information

Severity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root

Severity of AS Degree of AV calcification (? Bicuspid AV), annulus size, & aortic root The role of Cardiac Imaging modalities in evaluation & selection of patients for Trans-catheter Aortic Valve Implantation Dr.Saeed AL Ahmari Consultant Cardiologist Prince Sultan Cardaic Center, Riyadh

More information

Index. B B-type natriuretic peptide (BNP), 76

Index. B B-type natriuretic peptide (BNP), 76 Index A ACCESS-EU registry, 158 159 Acute kidney injury (AKI), 76, 88 Annular enlargement, RV, 177 178 Annuloplasty chordal cutting, 113 complete ring, 99 etiology-specific ring, 100 evolution, 98 flexible

More information

Aortic valve implantation using the femoral and apical access: a single center experience.

Aortic valve implantation using the femoral and apical access: a single center experience. Aortic valve implantation using the femoral and apical access: a single center experience. R. Hoffmann, K. Brehmer, R. Koos, R. Autschbach, N. Marx, G. Dohmen Rainer Hoffmann, University Aachen, Germany

More information

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor Cardiothoracic Radiology Disclosure I have no disclosure pertinent to this presentation.

More information

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo

More information

Mitral Valve Disease, When to Intervene

Mitral Valve Disease, When to Intervene Mitral Valve Disease, When to Intervene Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Current ACC/AHA guideline Stages

More information

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter

Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Options for my no option Patients Treating Heart Conditions Via a Tiny Catheter Nirat Beohar, MD Associate Professor of Medicine Director Cardiac Catheterization Laboratory, Medical Director Structural

More information

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved Transcatheter Aortic Valve Replacement Symptomatic Aortic Stenosis Asymptomatic Juan Crestanello, MD Interim Director, Division of Cardiac Surgery Associate Professor Division of Cardiac Surgery The Ohio

More information

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat Innovative Procedures, Devices & State of the Art Care for Arrhythmias, Heart Failure & Structural Heart Disease October 8-10,

More information

Francesco Fulvio Faletra Gila Perk Natesa G. Pandian Hans-Joachim Nesser Itzhak Kronzon. Real-Time 3D Interventional Echocardiography

Francesco Fulvio Faletra Gila Perk Natesa G. Pandian Hans-Joachim Nesser Itzhak Kronzon. Real-Time 3D Interventional Echocardiography Francesco Fulvio Faletra Gila Perk Natesa G. Pandian Hans-Joachim Nesser Itzhak Kronzon Real-Time 3D Interventional Echocardiography 123 Real-Time 3D Interventional Echocardiography Francesco Fulvio Faletra

More information

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis Similarities and differences in Tricuspid vs. Mitral Valve Anatomy and Imaging. Echo evaluation

More information

ECHOCARDIOGRAPHY DATA REPORT FORM

ECHOCARDIOGRAPHY DATA REPORT FORM Patient ID Patient Study ID AVM - - Date of form completion / / 20 Initials of person completing the form mm dd yyyy Study period Preoperative Postoperative Operative 6-month f/u 1-year f/u 2-year f/u

More information

Milind Desai Christine Jellis Teerapat Yingchoncharoen Editors. An Atlas of Mitral Valve Imaging

Milind Desai Christine Jellis Teerapat Yingchoncharoen Editors. An Atlas of Mitral Valve Imaging Milind Desai Editors An Atlas of Mitral Valve Imaging 123 An Atlas of Mitral Valve Imaging Milind Desai Editors An Atlas of Mitral Valve Imaging Editors Milind Desai Department of Cardiovascular Medicine

More information

8/31/2016. Mitraclip in Matthew Johnson, MD

8/31/2016. Mitraclip in Matthew Johnson, MD Mitraclip in 2016 Matthew Johnson, MD 1 Abnormal Valve Function Valve Stenosis Obstruction to valve flow during that phase of the cardiac cycle when the valve is normally open. Hemodynamic hallmark - pressure

More information

Handbook for Venous Thromboembolism

Handbook for Venous Thromboembolism Handbook for Venous Thromboembolism Gregory Piazza Benjamin Hohlfelder Samuel Z. Goldhaber Handbook for Venous Thromboembolism Gregory Piazza Cardiovascular Division Harvard Medical School Brigham and

More information

Valvular Heart Disease in Clinical Practice

Valvular Heart Disease in Clinical Practice Valvular Heart Disease in Clinical Practice Michael Y. Henein Editor Valvular Heart Disease in Clinical Practice 123 Editor Michael Y. Henein Consultant Cardiologist Umea Heart Centre Umea University

More information

Introducing the COAPT Trial

Introducing the COAPT Trial physician INFORMATION Eligible patients Symptomatic functional mitral regurgitation 3+ Not suitable candidates for open mitral valve surgery NYHA functional class II, III, or ambulatory IV Introducing

More information

Health-Related Quality of Life in Cardiovascular Patients

Health-Related Quality of Life in Cardiovascular Patients Health-Related Quality of Life in Cardiovascular Patients Kalina Kawecka-Jaszcz Marek Klocek Beata Tobiasz-Adamczyk Christopher J. Bulpitt Editors Health-Related Quality of Life in Cardiovascular Patients

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip

More information

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More? CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology

More information

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation Ömer Aktug 1, MD; Guido Dohmen 2, MD; Kathrin Brehmer 1, MD; Verena Deserno 1 ; Ralf Herpertz 1 ; Rüdiger

More information

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision

A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision A Surgeon s Perspective Guidelines for the Management of Patients with Valvular Heart Disease Adapted from the 2006 ACC/AHA Guideline Revision Prof. Pino Fundarò, MD Niguarda Hospital Milan, Italy Introduction

More information

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013

Imaging in TAVI. Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Imaging in TAVI Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Research grants: Medtronic, Biotronik, Boston Scientific, St Jude, BMS imaging, GE Healthcare,

More information

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris

Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives Bernard Iung Bichat Hospital, Paris Euro Heart Survey on Valvular Diseases 3547 Patients with Native Valve Disease n= 1250 1000

More information

Interventional procedures guidance Published: 26 July 2017 nice.org.uk/guidance/ipg586

Interventional procedures guidance Published: 26 July 2017 nice.org.uk/guidance/ipg586 Transcatheter aortic valve implantation for aortic stenosis Interventional procedures guidance Published: 26 July 17 nice.org.uk/guidance/ipg586 Your responsibility This guidance represents the view of

More information

Robotic Cardiac Surgery

Robotic Cardiac Surgery Robotic Cardiac Surgery Changqing Gao Editor Robotic Cardiac Surgery Editor Changqing Gao, MD Department of Cardiovascular Surgery PLA General Hospital Beijing Peoples s Republic of China ISBN 978-94-007-7659-3

More information

Percutaneous Mitral Valve Repair

Percutaneous Mitral Valve Repair Percutaneous Mitral Valve Repair Policy Number: Original Effective Date: MM.06.027 08/01/2015 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 08/01/2017 Section: Surgery Place(s)

More information

Percutaneous Mitral Valve Repair. Transesophageal Echo Acquisition Guide

Percutaneous Mitral Valve Repair. Transesophageal Echo Acquisition Guide TEE Screening MitraClip Percutaneous Mitral Valve Repair Transesophageal Echo Acquisition Guide Suggested Settings n Each view should be performed with and without color flow Doppler using color compare

More information

ETNA Foundation. Promoted by: in co-operation with: S. Raffaele Hospital University of Milan - ITALY Ferrarotto Hospital

ETNA Foundation. Promoted by: in co-operation with: S. Raffaele Hospital University of Milan - ITALY Ferrarotto Hospital ram Prog nces t Adva ewes gh N hrou ce T ellen Exc Promoted by: in co-operation with: ETNA Foundation S. Raffaele Hospital University of Milan - ITALY Ferrarotto Hospital Evanston Hospital University of

More information

Conflict of Interests

Conflict of Interests Introduction to Interventional Echocardiography Roberto M Lang, MD Tomtec Conflict of Interests Research Grants Philips Medical Imaging Research Grants Speakers bureau Advisory bureau 1 Structural Heart

More information

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine

Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Chapter 24: Diagnostic workup and evaluation: eligibility, risk assessment, FDA guidelines Ashwin Nathan, MD, Saif Anwaruddin, MD, FACC Penn Medicine Mitral regurgitation, regurgitant flow between the

More information

Update on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center

Update on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center Update on Percutaneous Therapies for Structural Heart Disease William Thomas MD Director of Structural Heart Program Tucson Medical Center NCVH 2014- Tucson Disclosure of Financial Interest Research: Stock

More information

ΔΙΑΔΕΡΜΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΟΜΙΚΩΝ ΠΑΘΗΣΕΩΝ: Ο ΡΟΛΟΣ ΤΗΣ ΑΠΕΙΚΟΝΙΣΗΣ ΣΤΟ ΑΙΜΟΔΥΝΑΜΙΚΟ ΕΡΓΑΣΤΗΡΙΟ ΣΤΗΝ ΤΟΠΟΘΕΤΗΣΗ MITRACLIP

ΔΙΑΔΕΡΜΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΟΜΙΚΩΝ ΠΑΘΗΣΕΩΝ: Ο ΡΟΛΟΣ ΤΗΣ ΑΠΕΙΚΟΝΙΣΗΣ ΣΤΟ ΑΙΜΟΔΥΝΑΜΙΚΟ ΕΡΓΑΣΤΗΡΙΟ ΣΤΗΝ ΤΟΠΟΘΕΤΗΣΗ MITRACLIP ΔΙΑΔΕΡΜΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ ΔΟΜΙΚΩΝ ΠΑΘΗΣΕΩΝ: Ο ΡΟΛΟΣ ΤΗΣ ΑΠΕΙΚΟΝΙΣΗΣ ΣΤΟ ΑΙΜΟΔΥΝΑΜΙΚΟ ΕΡΓΑΣΤΗΡΙΟ ΣΤΗΝ ΤΟΠΟΘΕΤΗΣΗ MITRACLIP ΒΛΑΣΗΣ ΝΙΝΙΟΣ MD MRCP ΚΛΙΝΙΚΗ ΑΓΙΟΣ ΛΟΥΚΑΣ ΘΕΣΣΑΛΟΝΙΚΗ CONFLICT OF INTEREST PROCTOR

More information

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

Valvular Regurgitation: Can We Do Better Than Colour Doppler? Valvular Regurgitation: Can We Do Better Than Colour Doppler? A/Prof David Prior St Vincent s Hospital Melbourne Sports Cardiology Valvular Regurgitation Valve regurgitation volume loads the ventricles

More information

e Corrado Tamburino, MD, PhD

e Corrado Tamburino, MD, PhD Transcatheter Aortic Valve Implantation Stroke: etiology ogy and prevention e Corrado Tamburino, MD, PhD Full Professor of Cardiology, Director of Postgraduate School of Cardiology Chief Cardiovascular

More information

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech

Disclosures. ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Disclosures ESC Munich 2012 Bernard Iung, MD Consultancy: Abbott Boehringer Ingelheim Bayer Servier Valtech Speaker s fee Edwards Lifesciences Sanofi-Aventis Decision Making in Patients with Multivalvular

More information

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Charanjit S. Rihal MD MBA Professor and Chair Division of Cardiovascular Diseases Mayo Clinic DISCLOSURES

More information

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 Imaging MV Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015 MV/MR: information needed on.. 1. MV anatomy 2. MR etiology - primary vs secondary 3. MR severity quantification

More information

How to assess ischaemic MR?

How to assess ischaemic MR? ESC 2012 How to assess ischaemic MR? Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology University Hospital Sart Tilman, Liège ESC 2012 No conflict of interest Luc

More information

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC

Disclosure Statement of Financial Interest Saibal Kar, MD, FACC MitraClip Therapy Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Program Director, Interventional Cardiology Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

More information

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain

Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Eulogio Garcia MD Hospital Clínico San Carlos Madrid - Spain Device Landscape 2010 PERCUTANEOUS TECHNIQUES Percutaneous indirect annuloplasty Percutaneous direct annuloplasty Edge to Edge ( E-Valve ) Non

More information

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines Advances in Percutaneous Mitral Valve Repair and Replacement Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando,

More information

VALVULOPATIE: NUOVE SOLUZIONI.

VALVULOPATIE: NUOVE SOLUZIONI. VALVULOPATIE: NUOVE SOLUZIONI www.fisiokinesiterapia.biz Nkomo, Lancet 2006 ELDERLY POPULATION PROJECTION IN USA 65-84 Years Old 85 and Older 77,2 Millions of people 34,8 4,3 30,5 53,8 6,8 47 14,3 62,9

More information

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease TIRONE E. DAVID, MD ; SEMIN THORAC CARDIOVASC SURG 19:116-120c 2007 ELSEVIER INC. PRESENTED BY INTERN 許士盟 Mitral valve

More information

TAVR: Echo Measurements Pre, Post And Intra Procedure

TAVR: Echo Measurements Pre, Post And Intra Procedure 2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate

More information

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation Susheel Kodali, MD Director, Structural Heart & Valve

More information

John Papadopoulos David R. Schwartz Consulting Editor. Pocket Guide to Critical Care Pharmacotherapy Second Edition

John Papadopoulos David R. Schwartz Consulting Editor. Pocket Guide to Critical Care Pharmacotherapy Second Edition John Papadopoulos David R. Schwartz Consulting Editor Pocket Guide to Critical Care Pharmacotherapy Second Edition 123 Pocket Guide to Critical Care Pharmacotherapy John Papadopoulos Author David R. Schwartz

More information

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Regurgitant Lesions Bicol Hospital, Legazpi City, Philippines July 2016 Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA Aortic Insufficiency Valve anatomy and function LVOT and

More information

When Does 3D Echo Make A Difference?

When Does 3D Echo Make A Difference? When Does 3D Echo Make A Difference? Wendy Tsang, MD, SM Assistant Professor, University of Toronto Toronto General Hospital, University Health Network 1 Practical Applications of 3D Echocardiography Recommended

More information

Euro Heart Survey New Programme Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI

Euro Heart Survey New Programme Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI Euro Heart Survey New Programme 2009-2012 Sentinel Registry Transcatheter Valve Treatment (TCVT) Carlo Di Mario, London, UK President EAPCI Alan Cribier, Rouen, France Andreas Gruentzig Award 2010 Cardiogenic

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH Available systems: Edwards (TA and TF) and Core valve. INTRODUCTION 3 4% 0f > 65 y. 30 40% of elderly denied surgery,.

More information

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes

8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes 8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference 2017 OSPEDALE Dubai: 19-21 October 2017 Acute Coronary Syndromes Antonio Colombo Centro Cuore Columbus and S. Raffaele

More information

Heart Team For TAVI Who and How?

Heart Team For TAVI Who and How? 2 nd TAVI Summit 2012, Seoul Corea Heart Team For TAVI Who and How? Alain Cribier, MD, Charles Nicolle Hospital University of Rouen, France Disclosure Edwards Lifesciences Consultant Training / proctoring

More information

7 th Conference of Transcatheter Heart Valve Therapies

7 th Conference of Transcatheter Heart Valve Therapies 7 th Conference of Transcatheter Heart Valve Therapies May 18-19, 2018, Athens Hilton Athens, Greece Course Directors Stratis Pattakos MD Konstantinos Spargias MD Panos Vardas MD Co-Directors Nick Bouboulis

More information

Repair or Replacement

Repair or Replacement Surgical intervention post MitraClip Device: Repair or Replacement Saudi Heart Association, February 21-24 Rüdiger Lange, MD, PhD Nicolo Piazza, MD, FRCPC, FESC German Heart Center, Munich, Germany Division

More information

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips

HIGHLIGHT SESSION. Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips Imaging. J. L. Zamorano Gomez (Madrid, ES) Disclosures: Speaker Philips Agenda ECHO Diagnosis & Prognosis : Functional MR Severity Aortic Stenosis CT How to select pts for TAVI Adding prognostic info to

More information

What echo measurements are key prior to MitraClip?

What echo measurements are key prior to MitraClip? APHP CHU Bichat - Claude Bernard What echo measurements are key prior to MitraClip? Eric Brochet,MD Cardiology Department Hopital Bichat Paris France No disclosure Conflict of interest Case 69 y.o man

More information

Dr Winnie Sze-Wun Chan. Cardiac Team Deputy Team Head Department of Radiology and Imaging Queen Elizabeth Hospital Hong Kong

Dr Winnie Sze-Wun Chan. Cardiac Team Deputy Team Head Department of Radiology and Imaging Queen Elizabeth Hospital Hong Kong Dr Winnie Sze-Wun Chan Cardiac Team Deputy Team Head Department of Radiology and Imaging Queen Elizabeth Hospital Hong Kong Why? Is CT reliable? How to perform the CT study? How to interpret the CT study?

More information

Policy Specific Section: March 30, 2012 March 7, 2013

Policy Specific Section: March 30, 2012 March 7, 2013 Medical Policy Transcatheter Aortic Valve Replacement for Aortic Stenosis Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date:

More information

Ischemic Mitral Regurgitation

Ischemic Mitral Regurgitation Ischemic Mitral Regurgitation Jean-Louis J. Vanoverschelde, MD, PhD Université catholique de Louvain Brussels, Belgium Definition Ischemic mitral regurgitation is mitral regurgitation due to complications

More information

Clinical Echocardiography

Clinical Echocardiography Clinical Echocardiography Michael Y. Henein Editor Mary Sheppard John R. Pepper Michael Rigby Associate Editors Clinical Echocardiography Second Edition Editor Michael Y. Henein, M.D. Department of Public

More information

Cardiac Valve/Structural Therapies

Cardiac Valve/Structural Therapies Property of Dr. Chad Rammohan Cardiac Valve/Structural Therapies Chad Rammohan, MD FACC Medical Director, El Camino Hospital Cardiac Catheterization Lab Director, Interventional and Structural Cardiology,

More information

Percutaneous mitral valve repair: current techniques and results

Percutaneous mitral valve repair: current techniques and results Percutaneous mitral valve repair: current techniques and results Ted Feldman, M.D., FSCAI, FACC Angioplasty Summit April 25-27 th th 2007 Seoul, Korea Ted Feldman MD, FACC, FSCAI Disclosure Information

More information

Dr. Jean-Claude Laborde

Dr. Jean-Claude Laborde Medtronic CoreValve Experience Alternative Access (Subclavian) and Technology Evolution of the Medtronic CoreValve TAVI System Dr. Jean-Claude Laborde Glenfield Hospital, Leicester, U.K. St George Hospital,

More information

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL

PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL PERCUTANEOUS MITRAL VALVE THERAPIES 13 TH ANNUAL CARDIAC, VASCULAR AND STROKE CARE CONFERENCE PIEDMONT ATHENS REGIONAL DISCLOSURES I WILL BE DISCUSSING OFF-LABEL USAGE OF DEVICES RELATED TO TMVR OBJECTIVES

More information

Aortic Regurgitation & Aorta Evaluation

Aortic Regurgitation & Aorta Evaluation VALVULAR HEART DISEASE Regurgitation Valvular Lessions 2017 Aortic Regurgitation & Aorta Evaluation Jorge Eduardo Cossío-Aranda MD, FACC Chairman of Outpatient Care Department Instituto Nacional de Cardiología

More information

Transcatheter aortic valve implantation for aortic stenosis

Transcatheter aortic valve implantation for aortic stenosis NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Transcatheter aortic valve implantation for aortic stenosis Aortic stenosis occurs when the aortic valve

More information

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC NATURAL HISTORY OF MITRAL REGURGITATION Abdallah El Sabbagh et al. JIMG 2018;11:628-643 TREATMENT OPTIONS SURGERY REPAIR REPLACEMENT PERCUTANEOUS INTERVENTIONS

More information

Imaging of Urinary Tract Diverticula

Imaging of Urinary Tract Diverticula Imaging of Urinary Tract Diverticula Vladimir M. Builov Imaging of Urinary Tract Diverticula Vladimir M. Builov Department of X-Ray and MRI RailWay Clinical Hospital Yaroslavl Russia ISBN 978-3-319-05382-0

More information

Echo Assessment Pre-TAVI

Echo Assessment Pre-TAVI Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial Interest /arrangement or affiliation with the organization(s) listed below Echocardiographic

More information

Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management

Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management Who will Benefit from Percutaneous Management of Mitral Regurgitation? An Imaging Guide to Management James D. Thomas, M.D., F.A.C.C. Department of Cardiovascular Medicine Heart and Vascular Institute

More information

What are the best diagnostic tools to quantify aortic regurgitation?

What are the best diagnostic tools to quantify aortic regurgitation? What are the best diagnostic tools to quantify aortic regurgitation? Agnès Pasquet, MD, PhD Pôle de Recherche Cardiovasculaire Institut de Recherche Expérimentale et Clinique Université catholique de Louvain

More information

Ανεπάρκεια Τριγλώχινας Επιλογή Επεμβατικής Θεραπείας. Μ. Χρυσοχέρης Τμήμα Διαδερμικών Βαλβίδων ΔΘΚΑ ΥΓΕΙΑ

Ανεπάρκεια Τριγλώχινας Επιλογή Επεμβατικής Θεραπείας. Μ. Χρυσοχέρης Τμήμα Διαδερμικών Βαλβίδων ΔΘΚΑ ΥΓΕΙΑ Ανεπάρκεια Τριγλώχινας Επιλογή Επεμβατικής Θεραπείας Μ. Χρυσοχέρης Τμήμα Διαδερμικών Βαλβίδων ΔΘΚΑ ΥΓΕΙΑ Disclosures - Proctoring activities for Abbott Vascular, Edwards Lifesciences I and the HYGEIA Hospital

More information

Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA

Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA Status Of The MitraClip: Trials (EVEREST II & COAPT) & FDA Ted Feldman, M.D., FSCAI FACC FESC Evanston Hospital SCAI Fall Fellows Course Las Vegas, Nevada December 8 11 th, 2013 Ted Feldman MD, FACC, FESC,

More information

Preprocedural evaluation for TAVR

Preprocedural evaluation for TAVR KEBE 30/05/15 Preprocedural evaluation for TAVR Ioannis Iakovou, MD, PhD Interventional Cardiology Onassis Cardiac Surgery Center Athens, Greece Clinical Pathway: Developing Peri- Procedural Protocols

More information

Case 47 Clinical Presentation

Case 47 Clinical Presentation 93 Case 47 C Clinical Presentation 45-year-old man presents with chest pain and new onset of a murmur. Echocardiography shows severe aortic insufficiency. 94 RadCases Cardiac Imaging Imaging Findings C

More information

Reverse left atrium and left ventricle remodeling after aortic valve interventions

Reverse left atrium and left ventricle remodeling after aortic valve interventions Reverse left atrium and left ventricle remodeling after aortic valve interventions Alexandra Gonçalves, Cristina Gavina, Carlos Almeria, Pedro Marcos-Alberca, Gisela Feltes, Rosanna Hernández-Antolín,

More information

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo

New York Valves Patient focused evidence-based approach. New York City: 6 December Antonio Colombo New York Valves 2018 Patient focused evidence-based approach New York City: 6 December 2018 Antonio Colombo Speaker 7 EMO GVM Centro Cuore Columbus Milan, Italy No conflicts to report Vascular complications

More information

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min 2016 ASE State of the Art Echocardiography Course Tucson, AZ How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, 2016 11:00 11:25 PM 25 min 1 M U H A M E D S A R I Ć, M D, P H D

More information

Valvular Intervention

Valvular Intervention Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Catheter-based mitral valve repair MitraClip System

Catheter-based mitral valve repair MitraClip System Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular

More information

Investigational Device only in the U.S. Not available for sale in the U.S. ACCESS EU European Society of Cardiology

Investigational Device only in the U.S. Not available for sale in the U.S. ACCESS EU European Society of Cardiology Early hemodynamic and echocardiographic outcomes after percutaneous MitraClip therapy in patients with mitral regurgitation. Preliminary results of the MitraClip arm of the ACCESS EUROPE registry. Jörg

More information

Percutaneous Mitral Valve Repair. Transthoracic Echo Acquisition Guide

Percutaneous Mitral Valve Repair. Transthoracic Echo Acquisition Guide TTE Screening MitraClip Percutaneous Mitral Valve Repair Transthoracic Echo Acquisition Guide Settings and General Comments n Digital archived images should include three (3) or more cardiac cycles unless

More information

Alexander N. Sencha Elena V. Evseeva Mikhail S. Mogutov Yury N. Patrunov. Breast Ultrasound

Alexander N. Sencha Elena V. Evseeva Mikhail S. Mogutov Yury N. Patrunov. Breast Ultrasound Breast Ultrasound Alexander N. Sencha Elena V. Evseeva Mikhail S. Mogutov Yury N. Patrunov Breast Ultrasound Alexander N. Sencha Department of Ultrasound Diagnostics Yaroslavl Railway Clinic Yaroslavl

More information

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France Future Percutaneous Therapies for Mitral Valve Disease (Mitraclip,percutaneous annuloplasty and transcatheter valve implantation) Will they reach the TAVI s success? Alec Vahanian,FESC, FRCP (Edin.) Bichat

More information

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens MITRAL REGURGITATION IN PATIENT WITH SEVERE AORTIC VALVE STENOSIS Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens I HAVE NOTHING TO DECLARE Management

More information

2019 Qualified Clinical Data Registry (QCDR) Performance Measures

2019 Qualified Clinical Data Registry (QCDR) Performance Measures 2019 Qualified Clinical Data Registry (QCDR) Performance Measures Description: This document contains the 18 performance measures approved by CMS for inclusion in the 2019 Qualified Clinical Data Registry

More information

Pre-procedural CT angiography for Transcatheter Aortic Valve Implantation: What a Radiologist Needs to Know?

Pre-procedural CT angiography for Transcatheter Aortic Valve Implantation: What a Radiologist Needs to Know? Pre-procedural CT angiography for Transcatheter Aortic Valve Implantation: What a Radiologist Needs to Know? E O Dwyer, C O Brien, I Murphy, C Shortt, O Buckley Department of Radiology, AMNCH, Dublin,

More information

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data

Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Transcatheter Aortic Valve Replacement: Current and Future Devices: How do They Work, Eligibility, Review of Data Echo Florida 2013 Jonathan J. Passeri, M.D. Co-Director, Heart Valve Program Director,

More information

Congenital Heart Disease

Congenital Heart Disease Congenital Heart Disease Morphological and Functional Assessment Hideaki Senzaki Satoshi Yasukochi Editors 123 Congenital Heart Disease Hideaki Senzaki Satoshi Yasukochi Editors Congenital Heart Disease

More information

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation

Imaging Assessment of Aortic Stenosis/Aortic Regurgitation Imaging Assessment of Aortic Stenosis/Aortic Regurgitation Craig E Fleishman, MD FACC FASE The Heart Center at Arnold Palmer Hospital for Children, Orlando SCAI Fall Fellows Course 2014 Las Vegas Disclosure

More information

Hafþór Ingi Ragnarsson. Thesis for the Degree of Bachelor of Science University of Iceland Faculty of Medicine School of Health Sciences

Hafþór Ingi Ragnarsson. Thesis for the Degree of Bachelor of Science University of Iceland Faculty of Medicine School of Health Sciences Rates of and predictors for the need of permanent pacemaker and its long-term utilization in patients undergoing surgical or transcatheter aortic valve replacement Hafþór Ingi Ragnarsson Thesis for the

More information

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know James F. Burke, MD Program Director Cardiovascular Disease Fellowship Lankenau Medical Center Disclosure Dr. Burke has no conflicts

More information